BLOOD-PRESSURE AND HEART-RATE AND WITHDRAWAL OF ANTIHYPERTENSIVE DRUGS

被引:54
作者
GOLDBERG, AD [1 ]
RAFTERY, EB [1 ]
WILKINSON, P [1 ]
机构
[1] NORTHWICK PK HOSP & CLIN RES CTR,DEPT CARDIOL,HARROW,MIDDLESEX,ENGLAND
关键词
D O I
10.1136/bmj.1.6071.1243
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1243 / 1246
页数:4
相关论文
共 10 条
[1]   ADRENERGIC NEURONE BLOCKING AGENTS [J].
BOURA, ALA ;
GREEN, AF .
ANNUAL REVIEW OF PHARMACOLOGY, 1965, 5 :183-+
[2]  
DAVIES DS, 1976, CLINICAL SCI MOLECUL, V51, P6395
[3]  
FURST CI, 1967, ADV DRUG RES, V4, P133
[4]  
GOLDBERG AD, 1976, POSTGRAD MED J, V52, P104
[5]  
GOLDBERG AD, 1976, POSTGRAD MED J, V52, P128
[6]   BLOOD-PRESSURE CRISIS FOLLOWING WITHDRAWAL OF CLONIDINE (CATAPRES, CATAPRESAN), WITH SPECIAL REFERENCE TO ARTERIAL AND URINARY CATECHOLAMINE LEVELS, AND SUGGESTIONS FOR ACUTE MANAGEMENT [J].
HANSSON, L ;
HUNYOR, SN ;
JULIUS, S ;
HOOBLER, SW .
AMERICAN HEART JOURNAL, 1973, 85 (05) :605-610
[7]   STUDIES ON CATECHOLAMINES, RENIN AND ALDOSTERONE FOLLOWING CATAPRESAN (2-(2,6-DICHLOR-PHENYLAMINE)-2-IMIDAZOLINE HYDROCHLORIDE) IN HYPERTENSIVE PATIENTS [J].
HOKFELT, B ;
HEDELAND, H ;
DYMLING, JF .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1970, 10 (03) :389-+
[8]  
HOOBLER SW, 1969, CATAPRES HYPERTENSIO, P116
[9]   PRESYNAPTIC REGULATION OF CATECHOLAMINE RELEASE [J].
LANGER, SZ .
BIOCHEMICAL PHARMACOLOGY, 1974, 23 (13) :1793-1800
[10]  
1975, CIRCULATION, V51, P1107